Herzuma 440 mg (Trastuzumab KIT) 440 MG

Herzuma 440 mg is a cancer treatment medication containing trastuzumab. It is used to target specific proteins in certain types of cancer cells. This intravenous kit is manufactured by Celltrion Inc. in South Korea.

Strength

440 MG

Manufacturer / TM Owner

CELLTRION INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Herzuma 440 mg is primarily used in the treatment of specific types of cancer. It works by targeting and blocking the action of a protein called HER2, which is found in higher than normal amounts in some types of cancer cells. This medication is often used in combination with other cancer treatments to help slow or stop the growth of cancer cells. What is Herzuma used for? It is typically prescribed for breast cancer and stomach cancer that has spread to other parts of the body.

Side Effects

Common effects of Herzuma 440 mg may include fatigue, nausea, and vomiting. Some patients may also experience fever, chills, and weakness. These effects can vary from person to person and may not affect everyone who uses this medication.

Precautions & Warnings

Herzuma 440 mg should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Avoid Interactions

Herzuma 440 mg may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult with a healthcare professional before starting any new medication.

Frequently Asked Questions

Herzuma 440 mg is used in the treatment of certain types of cancer, specifically those that overexpress the HER2 protein.

Herzuma 440 mg is administered intravenously by a healthcare professional.

Common side effects may include fatigue, nausea, vomiting, fever, chills, and weakness.

Herzuma 440 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Herzuma 440 mg is manufactured by Celltrion Inc. in South Korea.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.